Form 8-K Shattuck Labs, Inc. For: Sep 30
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- S&P, Dow edge higher on Mideast deal hopes; SpaceX debut in focus
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Oil falls to near two-month lows as Trump calls off threatened strikes on Iran
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Wall St set to gain on tech rebound, Middle East in focus
H.C. Wainwright Downgrades Shattuck Labs (STTK) to Neutral
October 1, 2024 10:32 AM EDTH.C. Wainwright analyst Joseph Pantginis downgraded Shattuck Labs (NASDAQ: STTK) from Buy to Neutral.
The analyst comments "Despite encouraging early clinical data; shifting gears away from CD47. This morning, Shattuck announced that following a strategic review of its pipeline and its amassed CD47 data to date in... More
H.C. Wainwright Downgrades Shattuck Labs (STTK) to Neutral
October 1, 2024 10:32 AM EDTH.C. Wainwright analyst Joseph Pantginis downgraded Shattuck Labs (NASDAQ: STTK) from Buy to Neutral.
The analyst comments "Despite encouraging early clinical data; shifting gears away from CD47. This morning, Shattuck announced that following a strategic review of its pipeline and its amassed CD47 data to date in... More
